tiprankstipranks
Advertisement
Advertisement
Minerva Neurosciences Launches ATM Offering to Fund Trial
PremiumCompany AnnouncementsMinerva Neurosciences Launches ATM Offering to Fund Trial
3M ago
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
Premium
Company Announcements
Minerva Neurosciences Launches Key Phase 3 Test for Roluperidone in Schizophrenia
3M ago
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
Premium
Ratings
Tsao Maintains Hold on Minerva as Roluperidone Phase 3 Progress Balances Rising Losses; $7 Price Target Reaffirmed
3M ago
Minerva appoints Jim O’Connor as chief business officer
PremiumThe FlyMinerva appoints Jim O’Connor as chief business officer
5M ago
Minerva screens first patient in roluperidone trial
Premium
The Fly
Minerva screens first patient in roluperidone trial
5M ago
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
Premium
Market News
Why Is the VTI ETF Down Today? Daily Snapshot – 3/12/26
5M ago
Minerva reports Q4 adjusted EPS (64c) vs. (53c) last year
PremiumThe FlyMinerva reports Q4 adjusted EPS (64c) vs. (53c) last year
5M ago
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Update—3/10/26
5M ago
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/9/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—3/9/26
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100